Martin Shkreli, the 32-year-old chief executive of Turing Pharmaceuticals who gained infamy for jacking up the price of a life-saving drug to $750 a dose, from $13.50, has been arrested on suspicion that he illegally siphoned shares from a biotech firm he founded to pay for unrelated debts, Bloomberg reported Thursday morning. Update: Reuters confirmed that FBI agents arrested Shkreli early Thursday; he was wearing a hoodie as he was escorted from his Midtown Manhattan apartment tower.
Shkreli was ousted from the earlier firm he started, Retrophin Inc., in 2014, and the board of that company has sued him, accusing him of misappropriating money from Retrophin to pay off investors in his defunct hedge fund, MSMB Capital Management. The Securities and Exchange Commission is expected to file a civil suit against Shkreli that hews closely to the federal criminal case.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
5 humorously unhealthy cartoons about RFK Jr.Cartoons Artists take on medical innovation, disease spreading, and more
-
Brodet (fish stew) recipeThe Week Recommends This hearty dish is best accompanied by a bowl of polenta
-
Phone hacking: victory for Prince Harry?Talking Point Even those who do not share the royal's views about the press should 'commend' his dedication to pursuing wrongdoing
-
Chinese AI chatbot's rise slams US tech stocksSpeed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor dealSpeed Read The strike could have shut down major ports from Texas to Maine
-
Biden expected to block Japanese bid for US SteelSpeed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
-
Judges block $25B Kroger-Albertsons mergerSpeed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
-
Rupert Murdoch loses 'Succession' court battleSpeed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
-
Bitcoin surges above $100k in post-election rallySpeed Read Investors are betting that the incoming Trump administration will embrace crypto
-
Enron mystery: 'sick joke' or serious revival?Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
-
US charges Indian tycoon with bribery, fraudSpeed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
